PBYI

PBYI R&D to Revenue

27.18%Fiscal year

Period ending:

PBYI FY R&D/Revenue%
PBYI FY R&D/Revenue875.48%-419.28%
2007-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

PBYI r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 19 observations from Dec 31, 2007 to Dec 31, 2025.

Puma Biotechnology Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
27.1786%
23.8363%
21.3812%
22.9092%
28.3897%
43.3788%
48.7956%
65.6972%
750.1805%
0%
0%
0%
0%
0%
-293.9821%
0%
0%
0%
0%

Compare r&d to revenue

All PBYI financial metrics · PBYI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.